Profile: Bayer AG (BAYRY.PK)
24 Feb 2017
Bayer AG, incorporated on January 15, 1952, is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development, production and marketing of prescription pharmaceuticals, such as anticoagulants, treatments for hemophilia, multiple sclerosis, cancer, eye diseases, pulmonary hypertension, high blood pressure and infectious diseases; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Pharmaceuticals division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health segment is engaged in the development, production and marketing of over-the-counter medications, dermatology products and nutritional supplements. The Consumer Health Division markets mainly nonprescription products in the dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care, sun protection and cardiovascular risk prevention categories. These products include brands, such as Claritin, Aspirin, Aleve, Bepanthen/Bepanthol, Canesten, Dr. Scholl's and Coppertone.
The Crop Science segment is engaged in the development, production and marketing of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Crop Science Division has businesses in seeds, crop protection and nonagricultural pest control. The Crop Science Division is organized into two operating units: Crop Protection/Seeds and Environmental Science. Crop Protection/Seeds markets a range of portfolio of seeds along with chemical and biological pest management solutions, and provides customer service for modern and sustainable agriculture. Environmental Science focuses on nonagricultural applications, with a portfolio of pest control products and services designed for applications ranging from the home and garden sector to forestry.
The Animal Health segment is engaged in the development, production and marketing of veterinary medicines and animal grooming products. Covestro is engaged in the development, production and marketing of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, adhesives and sealants; and selected chemical intermediates.
Company Web Links
- BRIEF-Bayer confident it will receive CFIUS approval for Monsanto takeover
- Bayer sees pesticides profits stagnating before Monsanto takeover
- UPDATE 2-Bayer sees pesticides profits stagnating before Monsanto takeover
- BRIEF-Bayer eyes more robust growth in agriculture towards yr-end
- Covestro parent Bayer non-committal on any sale to industry peer